Thinking of joining a study?

Register your interest

NCT06692686 | NOT YET RECRUITING | Ankle Foot Orthosis (AFO)


AFO Prescription to Optimize Post-Stroke Function
Sponsor:

University of Texas at Austin

Information provided by (Responsible Party):

Rick Neptune

Brief Summary:

The overall goal of this study is to attain the highest possible health-related quality of life for individuals with lower-limb impairment through a clinical trial examining three different modern carbon fiber ankle-foot orthosis (AFO) treatment options targeting the rehabilitation of individuals post-stroke. To achieve this goal, the investigators will: 1. Identify the factors that significantly contribute to an individual's highest potential quality of life when considering each of the three available AFO design options, and 2. Develop prediction models of clinical performance using biomechanical function linked to the three AFO designs. Participants will be asked to: * Wear each of the three modern AFO designs for one month, after receiving therapy training and * Complete questionnaires and performance tests with each AFO. In addition, the subset of individuals participating in goal 2) will also be asked to: * Perform biomechanical analyses using high-speed cameras and force plates during different walking and balance tests with each AFO design.

Condition or disease

Ankle Foot Orthosis (AFO)

Stroke Patients

Post-Stroke Hemiparesis

Intervention/treatment

Ankle-foot orthoses (AFOs)

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 120 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : The Development of Patient-Centered Clinical AFO Prescription Guidelines to Optimize Post-Stroke Function and Quality of Life
Actual Study Start Date : 2025-05
Estimated Primary Completion Date : 2027-10
Estimated Study Completion Date : 2027-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * be a minimum of three months post-stroke
  • * be greater than 18 years of age
  • * have been prescribed either a semi-rigid or a custom-made articulating AFO
  • * wear their prescribed AFO for all primary mobility activity 7 days a week
  • * be able to walk at least 20 meters without manual assistance
  • * walk at least 10 meters per minute (12% of normal velocity) and no faster than 60 meters per minute (75% of normal velocity) during a 6-meter self-selected velocity walking test.
Exclusion Criteria
  • * having a condition that could significantly limit ambulation, including severe osteoarthritis, rheumatoid arthritis, congestive heart failure, or pre-existing neurological disorder other than post-stroke
  • * having one of the brace options be contraindicated for the patient
  • * having cognitive deficits that preclude their ability to provide consent for participation
  • * having an ankle plantar flexion contracture equal to or greater than 15 degrees plantar flexion with full knee extension
  • * having marked inversion or ankle plantar flexor spasticity that interferes with foot placement for stance

AFO Prescription to Optimize Post-Stroke Function

Location Details

NCT06692686


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...